Nicolas André
Results of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval-Compressed Multiagent and Metronomic Chemotherapy
Adriana Rose , Lauro Jose Gregianin , Erica Boldrini , Carla Macedo , Sima Ferman , Tatiana El Jaick Bonifácio Costa , Marcelo Scopinaro , Algemir Lunardi Brunetto , André Tesainer Brunetto , Milena Villarroel on behalf of the GALOP Latin American Pediatric Oncology Group Ewing Sarcoma Investigators have published in Pediatric Blood and Cancer the (...)
Maintenance therapy for pediatric sarcoma: full throttle ahead?
We are delighted to announcve a new Metronomics Global Health Initiative publication ! Maintenance therapy for pediatric sarcoma: full throttle ahead? has been publisahed in Current opinion in Oncology as part of a sarcoma special issue. The piece has been written with Nadege Corradini from the HOPe-Pediatric Hematolgy and Oncology Institute, Leon (...)
Myelodysplastic syndrome-post-cytotoxic therapy for pediatric low-grade glioma
A case report entitled : Myelodysplastic syndrome-post-cytotoxic therapy for pediatric low-grade glioma authored by Phoebe Power, Susannah Payne, Rebecca Walsh, Adam Nelson & Neevika Manoharan from Department of Pediatric Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA and Kids Cancer Centre, Sydney Children’s (...)
Metronomic chemotherapy in pediatric neuroblastoma
A review about metronomic chemotherapy and neuroblastoma written by Yi Jiang, Chengjun Xi, Chao Yang from the Children’s Hospital of Chongqing Medical University, Chongqing, China The review is entitled : Metronomic chemotherapy in pediatric neuroblastoma and has been published in Pediatric Discovery. The full text is freely available here Abstract (...)
Michael RETSKY
Michael Retsky (Ph.D in physics from University of Chicago) made a career change from physics to cancer research. He is Editor-in-Chief of Journal of Bioavailability and Bioequivalence, on staff at Harvard School of Public Health, faculty at University College London, and Prof Adj at UANL, Monterrey, Mexico. He was on Judah Folkman’s staff at Harvard (...)
Metronomic Chemotherapy in Pediatric Oncology: A Way Forward for Low-Income Countries?
This is an up to date review on metronomics for children living in Low Income Countries that has been posted on the Oncopedia website.You can find the pdf file bellow or you might log on the Oncopedia website where comments from oncologist will be added.
Sourire A La Vie
En collaboration avec les médecins, l’association Sourire à la Vie propose aux enfants porteurs d’un cancer des activités physiques et artistiques adaptées à l’extérieur de l’hôpital. Sur le lieu du stage, les activités sont organisées sur mesure en fonction de la fragilité des enfants. L’équipe médicale valide la particpation et organise les soins nécessaires pour (...)
Mark KIERAN
Dr. Kieran received his PhD from the University of Alberta and MD from the University of Calgary in Canada. He then completed a post-doctoral fellowship in molecular biology at the Pasteur Institute in Paris France followed by his residency in pediatrics at McGill University in Montreal, Canada. Dr Kieran then completed a fellowship in pediatric (...)
High-level Meeting on Non-communicable Diseases
High-level Meeting on Non-communicable Diseases Background The General Assembly in its resolution A/RES/65/238 decided that the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases shall be held on 19 and 20 September 2011 in New York and that the high-level meeting shall address the prevention and (...)
Cancer joins AIDS, malaria as global health issue
Cancer joins AIDS, malaria as global health issue The fight against diseases like AIDS, malaria and tuberculosis has made Seattle a center for global health. Now, increasingly, the battle is including cancer — which might seem ridiculously impossible. Isn’t it hard enough to fight infectious diseases in poor countries? Can we afford to start talking (...)
